Risk factors for late-onset hyponatremia and its influence on neonatal outcomes in preterm infants

Yoon-Joo Kim1, Jin A Lee2, Sohee Oh3

  • 1Department of Pediatrics, Jeju National University Hospital, Jeju, Korea.

Insights

Late-onset hyponatremia (LOH) affects 30% of preterm infants, linked to factors like prematurity and breast milk feeding. LOH increases risks for serious neonatal complications and prolonged hospital stays.

Area of Science:

  • Neonatology
  • Pediatric Nephrology
  • Clinical Pediatrics

Background:

  • Late-onset hyponatremia (LOH) is a common electrolyte imbalance in preterm infants after two weeks of age.
  • It results from a negative sodium balance due to insufficient intake or excessive renal/intestinal losses.
  • Immature organ function in preterm neonates predisposes them to LOH.

Purpose of the Study:

  • To identify risk factors associated with LOH in preterm infants.
  • To investigate the impact of LOH on neonatal outcomes.
  • To understand the clinical significance of LOH in this vulnerable population.

Main Methods:

  • Retrospective cohort analysis of 161 preterm infants (born <34 weeks gestation).
  • Data collected between June 2009 and December 2010 at Seoul National University Hospital.
  • LOH defined by serum sodium levels (≤132 mEq/L or 133-135 mEq/L with supplementation).

Main Results:

  • LOH occurred in 30.4% of infants.
  • Significant risk factors included lower gestational age, shorter parenteral nutrition, respiratory distress syndrome, furosemide use, and breast milk feeding.
  • LOH was associated with longer hospital stays and increased risks of bronchopulmonary dysplasia and retinopathy of prematurity.

Conclusions:

  • LOH is frequently observed in preterm infants.
  • It may serve as a risk factor for significant morbidities like bronchopulmonary dysplasia and retinopathy of prematurity.
  • LOH duration impacts the severity of outcomes, including BPD, PVL, and EUGR.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
851
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
210
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
443